In 2023, the U.S. Will Still Be the #1 Prescription Drug Spender in the World, IQVIA Forecasts
Health Populi
JANUARY 29, 2019
and emerging markets (coined “pharmerging” by IQVIA) will push up spending, while limiting factors on growth will be increasing generics and expiration of brand patents. will be followed by China, Japan, Germany, and Brazil in 2023. More philanthropic organizations targeting neglected tropical and public health diseases.
Let's personalize your content